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ABSTRACT 20	
Perfluorooctanoic acid (PFOA) is a persistent organic pollutant, which may possess 21	
endocrine disrupting properties. Herein, we investigated the possible mechanism(s) of 22	
toxicity and steroidogenesis in mouse Leydig cells. MLTC-1 (mouse Leydig tumour cells) 23	
cells were exposed to 0, 50, 100 or 200 µM PFOA for 48 h to ascertain their effects on the 24	
nuclear (membrane) receptor responses, steroidogenesis pathway and related regulated gene 25	
expression and steroid hormone secretion profiles. Our results reveal that nuclear receptor 26	
PXR, SR-B1 and LHR are sensitive to PFOA exposure. PFOA can accumulate in 27	
mitochondria and alter cholesterol precursor (fatty acid) mitochondrial transport 28	
process-related gene expression and thus inhibit steroid hormone precursor (cholesterol) 29	
production. In particular, PFOA exhibits biphasic effects on testosterone and progesterone 30	
production at differing levels of exposure. These findings indicate the potential 31	
endocrine-related effects of PFOA on steroid hormone secretion in Leydig cells and point to a 32	
novel disruption model. 33	
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1. Introduction 38	
Perfluorinated compounds (PFCs) are a group of synthetic chemical substances 39	
consisting of carbon-fluorine bonds, and well known for their uses in a wide range of 40	
industrial applications due to their unique properties of stability, lipophobicity and 41	
hydrophobicity. In recent years, widespread distribution of PFCs into different environmental 42	
matrices has become an important concern due to their bioaccumulation in different tissues of 43	
humans and wildlife [1]. Given its longer half-life, perfluorooctanoic acid (PFOA) is one of 44	
the most widely reported PFCs in exposed biological species [1]. The general population has 45	
both PFOA and perfluorooctanesulfonic acid (PFOS) typically present at blood 46	
concentrations ranging from approximately 10-100 nM [2, 3]. However, levels of PFOA in 47	
serum of occupationally-exposed workers can be 10 µM or higher [2, 4]. 48	
Recently, it has been suggested that PFOA might cause several health effects in animals 49	
and humans, including reproductive impairments, neurological disorders, liver toxicity and 50	
development abnormalities [5-7]. An in vivo animal toxicity study has shown that PFOA has 51	
the ability to cause several types of tumours, including in Leydig cells [8]. In particular, 52	
PFOA has been considered a potential endocrine disrupting chemical, causing male 53	
reproductive system-related abnormalities. Taking this into consideration, many studies have 54	
reported that PFOA may interrupt sex hormone functions either by decreasing serum 55	
testosterone (T) levels and/or increasing serum oestradiol (E2) levels in rodents [9, 10] and 56	
increasing serum testosterone and oestrone levels in fish species [11], disruption of gonad 57	
development in male fish [12], and altered human and rat steroidogenic enzyme activities [9, 58	
10, 13]. That said, human epidemiology studies into the relationship between PFOA 59	
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concentrations and hormone levels in humans have been inconsistent. Some studies suggest a 60	
negative association of PFOA levels with serum total testosterone and free testosterone, and a 61	
positive association with oestradiol [14-16]. In contrast, a positive relationship between total 62	
testosterone with concentrations of PFOA have also been reported [17], while no such 63	
associations were found in human epidemiology or in vitro toxicology studies [18, 19]. 64	
Similarly, a similarly ambiguous association of PFOA levels and semen quality has also been 65	
documented. For example, lower sperm concentrations and total sperm count per ejaculate 66	
were associated with in utero PFOA exposure levels [20]. High levels of PFOA were also 67	
associated with reduced numbers of normal human sperm [21]. Contrary to this, some studies 68	
suggest that there is no correlation between PFOA and human semen quality, including sperm 69	
concentration, count, volume, motility and morphology [21, 22]. 70	
Studies investigating the impact of PFOA on male reproductive health are controversial. 71	
Further studies will need to be undertaken to clarify the biological mechanisms underlying 72	
PFOA endocrine disruption. Testicular Leydig cells are the primary source of steroid 73	
hormone in the male. Steroid hormone production starts with cholesterol, which is converted 74	
into an intermediate prior to generation of the end product sex hormone, testosterone [23]. 75	
Mouse Leydig tumour cells (MLTC-1) are a useful model to study effects on steroidogenesis 76	
because of their steroidogenesis potency. In vivo and in vitro experiments also suggest that 77	
mouse Leydig cells appear to be more similar to human Leydig cells in their responses to 78	
environmental exposure than are those of the rat [24]. Consequently, mouse Leydig MLTC-1 79	
cells were selected for the in vitro model towards assessment of PFOA endocrine disruption. 80	
The aim of this study is to improve our understanding of PFOA-induced endocrine 81	
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disruption via molecular initiating events (receptor response) and endpoints (steroid hormone 82	
secretion) related to reproductive toxicity, by using mouse in vitro Leydig MLTC-1 cells. 83	
 84	
2. Materials and methods 85	
2.1. Chemicals and reagents 86	
PFOA (C8F15O2H; Chemical Abstract Service, no. 335-67-1; purity >96%) and isotope 87	
PFOA 13C8 was purchased from Cambridge Isotope Laboratories (Andover, MA, USA). 88	
Dimethyl sulfoxide (DMSO) was purchased from Sigma-Aldrich Chemical Co. (St. Louis, 89	
Mo. USA). Human chorionic gonadotrophin (hCG) was obtained from PROSPECT 90	
(Ness-Ziona, Israel). The steroid hormone standards of testosterone and 17-OH progesterone 91	
were purchased from Dr. Ehrenstorfer GmbH (Germany) and the isotope D3-testosterone was 92	
purchased from Cerilliant (Promochem, Wesel, Germany). All other chemicals of appropriate 93	
grades were commercially available. 94	
2.2. Cell culture and cell viability assay.  95	
The MLTC-1 cell line was obtained from the Cell Institute of Shanghai (Shanghai, 96	
China) and cultured in RPMI-1640 medium (Gibco BRL, Grand Island, NY) supplemented 97	
with 100 unit/mL penicillin, 100 unit/mL streptomycin and 10% (v/v) foetal bovine serum 98	
(Hyclone, USA). The cells were grown at 37℃ with 5% CO2 in a humidified incubator 99	
(SANYO, Japan). 100	
Cell viability was evaluated by the MTT proliferation assay. Cells were plated at a 101	
density of 1.5×104 per well in 96-well plates. After 48-h incubation at different 102	
concentrations of PFOA (0-300 µM), 50 µL MTT (5 mg/mL) was added to each well and the 103	
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cells were incubated for 4 h at 37℃. Untreated cells were used as a negative control. The 104	
medium was removed and 150 µL DMSO was added to each well and gentle shaking was 105	
then performed for 10 min. Absorbance was determined at 490 nm. Four replicates for each 106	
PFOA exposure were performed. Results were presented as percentage of the values 107	
measured in untreated control cells. To ensure absence of cytotoxicity, the concentrations 50 108	
µM, 100 µM, and 200 µM were selected for the following PFOA exposure experiments. 109	
2.3. PFOA treatment 110	
MLTC-1 cells were seeded in 6-cm petri dishes and cultured for 24 h prior to treatment. 111	
PFOA was dissolved in DMSO. Cells were exposed to 50 µM, 100 µM or 200 µM PFOA for 112	
48 h, with DMSO (0.1%) alone employed as a vehicle control. Four replicates for each dose 113	
of PFOA exposure were performed. Then, the cells were washed with PBS and serum-free 114	
medium. Subsequently, cells were stimulated for 4 h with hCG in serum-free medium 115	
supplemented by 0.1% BSA. The medium was collected for progesterone and testosterone 116	
determination, and the cells for cholesterol measurements and other biochemical assays. 117	
2.4. RNA extraction and quantitative real-time RT PCR analysis 118	
To determine mRNA expression levels, a quantitative real-time RT PCR assay was 119	
performed. Total RNA was extracted from the cells using an RNA extraction kit (Promega, 120	
USA), following the manufacturer’s protocol. Extracted RNA samples were stored at -80oC, 121	
for subsequent analyses. The NanoDrop spectrophotometer (NanoDrop Technologies Inc., 122	
USA) was used to measure RNA and/or DNA concentration and purity. 123	
Reverse transcription of cDNA synthesis was performed with 1 µg total RNA using 124	
PrimeScript® RT reagent Kit with gDNA Eraser cDNA synthesis Kits (Takara, Japan) 125	
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employing oligo dT primer. Real-time PCR was carried out in a 20 µL final volume and 126	
performed in triplicate using SYBR Green Master Mix reagents (Roche, USA) in a LC 480 127	
system (Roche Applied Science, Germany), according to the manufacturer’s protocol. Primer 128	
sets and product sizes used for amplification PCR analysis are shown as Table 1. The 129	
conditions for quantitative PCR were as follows: 95oC for 10 min followed by 40 cycles at 95℃ 130	
for 15 s, and 60℃ for 30 s. Gene expression levels were normalized to GAPDH expression 131	
levels. Three replicates of quantitative PCR were performed for each sample. Four replicates 132	
for each dose of PFOA exposure were performed. The fold changes of the tested genes were 133	
determined by the 2-ΔΔCt algorithm approach. 134	
2.5. Cholesterol, progesterone and testosterone determination 135	
Total cholesterol (TCHO) content in MLTC-1 cells in the control and PFOA groups 136	
were measured using commercial kits according to the manufacturer’s instructions (Beihua 137	
Kangtai Clinical Reagent, China). Total cholesterol concentration was normalized to Leydig 138	
cell protein concentration. Steroid hormones testosterone and progesterone levels in cell 139	
culture medium were detected by LC-ESI-MS/MS. In brief, each sample of 1 mL medium 140	
was diluted with 3 mL of ammonium acetate buffer (1 mol/L), and 20 µL of 100 ng/mL 141	
D3-testosterone internal standard was added (progesterone was semi-quantified). Then the 142	
diluted samples were extracted by adding 3 mL ethyl acetate and vortexed vigorously for 15 143	
seconds in a glass tube. The liquid-liquid extraction was repeated three times. The following 144	
phase separation was completed by centrifugation at 1500 rpm for 10 min. The ether phase 145	
was transferred to another glass tube with a Pasteur pipette. The three times extract was 146	
combined and washed with 5 mL water, then the combined extracts were evaporated under a 147	
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gentle stream of nitrogen gas at 40oC. The residue was reconstituted with 200 µL 148	
methanol/water (50:50, v:v) by vortexing vigorously for 15 sec and transfer into a HPLC vial. 149	
The sample was stored at -20oC until LC-MS-MS analysis. Two quality control samples and 150	
two sets of standards were analysed together with unknown samples in each analytical batch. 151	
2.6. Quantification of PFOA in cytoplasmic and mitochondrial fractions 152	
Mitochondrial isolation was performed using the Cell Mitochondria Isolation Kit 153	
(Beyotime Institute of Biotechnology, China) according to the manufacturer’s instructions. 154	
Briefly, MLTC-1 cells were pelleted, washed, and re-suspended in ice-cold mitochondria 155	
isolation buffer. The cells were homogenized and centrifuged at 600 g for 10 min at 4℃. The 156	
supernatant was centrifuged at 11,000 g for 10 min at 4℃ to obtain mitochondrial pellets. 157	
Mitochondrial-free cytoplasm was obtained from the supernatant. Mitochondrial pellets were 158	
lysed in a lysis buffer. 159	
Mitochondrial lysate and cytoplasm were extracted by ion-pair extraction and 160	
solid-phase extraction (SPE) with subsequent HPLC-MS/MS quantification method, as 161	
previously outlined [25, 26]. In brief, 0.03 ml of mitochondrial lysate was made up to 1 mL 162	
with distilled water in a 15 mL PP tube (containing 10 ng C13PFOA internal standard). Before 163	
extraction, the spiked samples were allowed to equilibrate overnight at room temperature 164	
(26℃). Then, 1 mL tetra-n-butylammoniumhydrogen sulfate and 2 mL sodium carbonate 165	
(0.25 M, pH 10) were added. After mixing, 5 mL MTBE was added, and the mixture was 166	
shaken for 15 min at 250 rpm. The organic and the aqueous layers were separated by 167	
centrifugation at 3000 rpm for 15 min. Then, 4 mL MTBE supernatant was removed and 168	
transferred to another 15 mL PP tube. This procedure was twice repeated, except that 5 mL 169	
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MTBE was collected each time. All three extracts were combined, and evaporated to dryness 170	
under a gentle stream of nitrogen at 45℃. Finally the dried residue was re-suspended in 0.5 171	
mL of methanol/water (50:50, v:v) before analysis. Calibration standards and QC samples 172	
were analysed concurrently with unknown samples using the same sample preparation 173	
procedure. 174	
2.7. Statistical analysis  175	
 Measurement data of cholesterol, progesterone, testosterone levels and gene 176	
expression by real-time RT PCR analysis were analysed using SPSS for Windows 11.5 177	
Software (SPSS, Inc., Chicago, IL) and were presented as mean with standard errors (mean ± 178	
SE). The experiments were repeated four times, each in duplicate. Data were analysed by 179	
one-way ANOVA with Tukey’s multiple comparisons test. Asterisks above columns indicate 180	
a significant difference in comparison to the control, *p ≤0.05, **p ≤0.01. 181	
 182	
3. Results 183	
3.1. Cell viability assay 184	
To analyse the effects of PFOA on MLTC-1 cell viability, the cells were treated with 185	
different doses (from 0 to 300 µM) of PFOA for 48 h. Results of cytotoxicity studies are 186	
shown in Figure 1. Taking into account effects on cell viability, the PFOA concentrations 187	
were kept below the levels (i.e., 300 µM) at which significant lethal effects occurred. 188	
Exposure concentrations in subsequent experiments were as follows: 0, 50, 100 or 200 µM. 189	
3.2. Nuclear (membrane) receptor responses to PFOA exposure 190	
As nuclear (membrane) receptor is involved in environmental exposure and 191	
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toxicological effects, transcript profiles of nuclear (membrane) receptor were investigated in 192	
MLTC-1 cells exposed to varying levels of PFOA. The mRNA expression of PPARα 193	
(PPAR-alpha; controls the peroxisomal β-oxidation pathway of fatty acids) was unaltered 194	
following PFOA exposure compared to control (Fig. 2). AR (androgen receptor; is activated 195	
by binding androgenic hormones and then regulates male sexual phenotype gene expression) 196	
gene exhibits significantly reduced expression following 50 or 100 µM PFOA, while no 197	
significant alteration is observed at the higher dose (i.e., 200 µM) PFOA treatment. PXR 198	
(Pregnane X receptor; regulates a broad range of genes involved in the transport, metabolism 199	
and elimination of foreign toxic substances) gene was significantly up-regulated in a 200	
dose-related fashion after PFOA exposure (p <0.05) (Fig. 2). There was no significant 201	
alteration found at lower levels of PFOA (i.e., 50 µM) on LHR (luteinizing hormone receptor; 202	
allows Leydig cells to respond to luteinizing hormone that triggers these cells to produce 203	
androgens) gene expression. However, 100 µM PFOA significantly induced (p <0.05) LHR 204	
expression (Fig. 2). However, significant down-regulation (p <0.01) was observed following 205	
200 µM PFOA exposure. Considering Figure 2, it can be identified that SR-B1	 (scavenger 206	
receptor B1; regulates cholesterol uptake) mRNA expression was significantly 207	
down-regulated (p <0.01) in all PFOA exposure groups, noticeably following 200 µM PFOA 208	
which declined to 0.16±0.04 folds compared to controls. SREBP2 (sterol regulatory 209	
element-binding protein 2; controls cholesterol homeostasis) result is consistent with the 210	
SR-B1 observation; SREBP2 expression significantly declined (0.74- to 0.51-fold compared 211	
to controls, p <0.01; Figure 2) with various concentrations of PFOA exposure in MLTC-1 212	
cells. 213	
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3.3. PFOA alters fatty acids transport into mitochondria 214	
Considering PFOA’s structural similarity to endogenous fatty acids, the potential 215	
interactive-relationship of PFOA and fatty acids in mitochondria were investigated by 216	
investigating PFOA subcellular mitochondrial distribution (Fig. 3A) and then determining 217	
candidate gene expression coding for enzymes involved in fatty acids mitochondrial transport 218	
(Fig. 3B and C). Our results confirm that PFOA can transport into subcellular mitochondria 219	
via PFOA accumulation. Figure 3A shows the subcellular accumulation of PFOA in 220	
cytoplasm and mitochondria. Following PFOA exposure, it was detected in both cytoplasmic 221	
and mitochondrial fractions. Following 100 µM PFOA exposure, the medium concentration 222	
of PFOA was 41.3±1.1 ppm, the PFOA content was 129.0±3.8 µg/g Pr (µg PFOA/g protein) 223	
in the cytoplasm and 6.4±0.3 µg/g Pr in mitochondria, respectively. Meanwhile, the control 224	
group PFOA content was 0.09 ±0.01 ppb, 1.0±0.1 µg/g Pr, and 0.7±0.1µg/g Pr in medium, 225	
cytoplasm and mitochondria, respectively. 226	
Meanwhile, CPTii (carnitine-palmitoyltransferase ii) responsible for connecting 227	
carnitine to long-chain fatty acids, which facilitates them crossing the outer mitochondrial 228	
membrane, was significantly down-regulated (p <0.05) (Fig. 3B, 3C). CACT 229	
(carnitine-acylcarnitine translocase) is a carnitine carrier protein, a component of the 230	
mitochondrial inner membrane and transfers fatty acylcarnitines into the mitochondria, was 231	
not significantly altered following different PFOA exposure levels (Fig. 3B, 3C). However, 232	
CPTii (carnitine-palmitoyltransferase ii), coding for the inner mitochondrial membrane 233	
protein that converts acylcarnitine to acyl-CoA for further fatty acid metabolism, was 234	
significantly (p <0.01) induced following 100 µM (1.34-fold) or 200 µM (1.69-fold) PFOA 235	
	 12	
(Fig. 3B). Mitochondrial matrix enzyme CRAT (carnitine acetyltransferase), that catalyses the 236	
inter-conversion of acetyl-CoA and acetylcarnitine, was also significantly (p <0.01) induced 237	
(1.71-fold) following 200 µM PFOA exposure (Fig. 3B, 3C). 238	
3.4. PFOA disturbs cholesterol synthesis transcriptional profile and secretion 239	
Cholesterol and steroid hormone biosynthesis is regulated by steroidogenic genes. The 240	
effects of PFOA exposure on expression of genes involved in cholesterol biosynthesis or 241	
steroidogenesis in MLTC-1 were determined (Fig. 4 and Table 2). Quantitative real-time 242	
RT-PCR assays results show that cholesterol biosynthesis pathway-related genes expression 243	
were down-regulated (0.29-0.87-fold) significantly (p <0.01) in the 200 µM PFOA-treated 244	
group compared to vehicle control. Interestingly, 50 µM PFOA exposure significantly (p 245	
<0.05) induced MVK (1.52-fold), PMVK (1.52-fold), MVD (1.23-fold), FOPS (1.35-fold) and 246	
CYP5 (1.74-fold) gene expression (Fig. 4, Table 2). Especially, HMGCR, an enzyme 247	
involved in mevalonate synthesis and is rate-limiting in the cholesterol synthesis pathway, 248	
was significantly down-regulated in a dose-related manner after PFOA exposure: 0.85-, 0.82-, 249	
and 0.36-fold for 50, 100 and 200 µM PFOA-treatment groups, respectively (Fig. 4, Table 2). 250	
Moreover, the effects of PFOA on cholesterol levels in MLTC-1 cells are shown as Figure 4C. 251	
Cholesterol was markedly decreased (p <0.05) to 0.83-, 0.87- and 0.85-fold of control 252	
following exposures of 50, 100 and 200 µM PFOA, respectively. 253	
3.5. Effects of PFOA on steroidogenesis pathway gene expression and steroid hormone 254	
secretion 255	
The expression of genes involved in steroidogenesis were significantly (p <0.01) 256	
decreased (0.37-0.71-fold) in the 200 µM PFOA-treatment groups compared to the vehicle 257	
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controls (Fig. 5A, 5B). The StAR gene, which is responsible for cholesterol transport to the 258	
inner mitochondrial membrane, was also significantly reduced (p <0.01) to 0.80-, 0.65- and 259	
0.37-fold of the controls in the 50, 100 and 200 µM PFOA-treated groups, respectively (Fig. 260	
5A, 5B). 3β-HSD gene, responsible for converting pregnenolone to progesterone, was 261	
markedly reduced (p <0.01) to 0.73-, 0.80- and 071-fold of the control in 50, 100 and 200 µM 262	
PFOA-treated groups, respectively (Fig. 5A, 5B). Similarly, CYP17α, which plays a 263	
significant role in steroid hormone synthesis, was also markedly reduced (p <0.01) to 264	
0.63-fold of the controls in the 200 µM PFOA-treated group (Fig. 5A, 5B). Interestingly, no 265	
significant differences between the PFOA treatment groups and controls are observed for 266	
P450SCC (catalyses cholesterol side-chain cleavage to pregnenolone) and 17β-HSD 267	
(catalyses androstenedione to testosterone) mRNA expression (Fig. 5A, 5B). 268	
The levels of 17-OH progesterone following 50 µM PFOA were above control levels, 269	
but no statistical difference was found. For the 100 µM PFOA groups, progesterone levels 270	
were significantly increased (p <0.01) to 1.31-fold of the control, whereas at 200 µM, 271	
progesterone were significantly reduced (p <0.01) to 0.53-fold of control (Fig. 5C). Similar to 272	
17-OH progesterone, PFOA exposure induced biphasic effects on testosterone production in 273	
MLTC-1 cells. PFOA effects at medium dose (100 µM) have significantly stimulatory effects 274	
(p <0.01) on testosterone production, i.e., 1.84-fold compared to controls, while significantly 275	
inhibitory (p <0.01) effects at higher exposures are noted, i.e., 0.50-fold at 200 µM compared 276	
to controls (Fig. 5D). 277	
 278	
 279	
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4. Discussion   280	
In the present study, we evaluated the mode of toxicity and steroidogenesis in mouse 281	
Leydig MLTC-1 cells following PFOA exposure to understand toxicological effects in the 282	
mouse testis and effects on steroid production. We demonstrate that PFOA has the ability to 283	
disrupt fatty acids transport, maybe due to the structural similarity of PFOA and endogenous 284	
fatty acids, inhibition of exogenous cholesterol uptake and endogenous cholesterol de novo 285	
production via reduced transport and synthesis metabolism pathway genes expression 286	
respectively, interruption of sex hormones secretion by altering cholesterol mitochondrial 287	
transport and impacting steroidogenic enzyme activity in MLTC-1 cells. PFOA has a 288	
non-monotonic effect on testosterone and 17-OH progesterone production with different 289	
levels of exposure. 290	
Multiple receptors are involved in the metabolic response to PFOA exposure in rodent 291	
liver cells. PPARα activation, involved in the regulation fatty acid β-oxidation, and Acox1 292	
(acyl CoA oxidase) is the down-stream target genes [27]. PPARα activation has been 293	
demonstrated in rat and mice liver treated with PFOA [27, 28]. In the present MLTC-1 cells 294	
study, PPARα receptor and Acox1 (data not shown) gene expression are not altered following 295	
any exposure of PFOA in Leydig cells. The results suggest that PPARα receptor in MLTC-1 296	
Leydig cells is less sensitive to PFOA exposure compared to previous liver cells. PXR is the 297	
molecular target for a wide range of endogenous and xenobiotic compounds. It is responsible 298	
for regulation of lipid metabolism and cholesterol homeostasis by mediating genes for 299	
cholesterol uptake (SR-B1) and efflux (ABCA1) [27, 29]. Our results reveal distinct patterns 300	
for the SR-B1 receptor and PXR gene expression after PFOA treatment in MLTC-1 cells. 301	
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PXR and SR-B1 were sensitive to PFOA, which is noticeable, in the 200 µM PFOA treatment 302	
group and the changes were 2.78- and 0.16-fold for both PXR and SR-B1 compared to 303	
controls, respectively. We infer that PFOA disrupts cytoplasmic cholesterol transport via 304	
inhibiting SR-B1 uptake function. LH via binding to its receptor (LHR) then controls 305	
steroidogenesis. It is noteworthy that the present findings provide novel evidence that PFOA 306	
plays a dual role in regulating LHR function in MLTC-1 cells, exhibiting induction at lower 307	
exposures (100 µM) PFOA and inhibition at higher levels (200 µM). Our results are also in 308	
agreement with previously reported findings, which also show that acute triiodothyronine 309	
exposure stimulates LHR expression, whereas chronic exposure attenuates LHR expression 310	
[30]. A possible mechanism may be related to the fact that high LHR levels sensitize 311	
testicular cells to LH and facilitate steroidogenesis, whereas, lower LHR levels differ in their 312	
effect, and maintenance of normal testosterone secretion requires additional LH secretion 313	
[30]. Our testosterone and progesterone results agree with this, and correlate with LHR 314	
expression. Hence, it cannot be ignored that PFOA has possible effects on sex hormones 315	
biosynthesis via LHR regulation, although the mechanism requires further exploration. 316	
PFCs have structural similarity with endogenous fatty acids, which can alter lipid 317	
profiles in liver via induction of hepatic fatty acids metabolism. The gene expression profile 318	
in PFOA-exposed rat liver also shows those largest categories of induced genes, which are 319	
involved in transport and metabolism of lipids, particularly fatty acids [31]. Our previous 320	
work also revealed that PFOA can alter the transport of long-chain fatty acids from the 321	
cytosol to mitochondrial matrix via carnitine shuttle [32]. Genes coding for enzymes 322	
responsible for unsaturated fatty acids transport have been altered by PFOA in MLTC-1 cells 323	
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(Fig. 3). According to our observation, it is shown that PFOA can inhibit mitochondrial outer 324	
membrane fatty acid import-related gene (CPTii), while inducing mitochondrial matrix fatty 325	
acid retransformation and oxidation metabolism products export-related gene (CPTii, CRAT) 326	
expression. Our results are consistent with a previous study that showed that PFOA induced 327	
CPTii and CRAT expression in human, rat and mouse liver cells [31-33]. Because of the 328	
structural resemblance of PFOA and endogenous fatty acids, PFOA can be taken up in the 329	
in-vitro cell model [34]. Kudo and co-authors imply that both PFOA and fatty acids can 330	
transfer into mitochondria, but PFOA is unable to metabolize via β-oxidation [35]. In 331	
agreement, we find that PFOA is transported into MLTC-1 cell cytoplasm and mitochondria. 332	
We	speculate that MLTC-1 cell reduces PFOA uptake by lowering CPTii expression, while 333	
facilitating PFOA elimination by increase CPTii and CRAT expression, which leads to 334	
disturbed fatty acids transport; further research is necessary to demonstrate this. 335	
Cholesterol is a main substrate for testosterone biosynthesis. Leydig cells can synthesise 336	
cholesterol in endoplasmic reticulum and use several potential sources of cholesterol for 337	
steroidogenesis in mitochondria [36]. Previous studies suggest that PFOA can disrupt 338	
cholesterol content by altering cholesterol transport and biosynthesis routes [9, 31, 32]. Our 339	
results show that PFOA significantly weakens the cholesterol content in MLTC-1 cells. The 340	
PXR and SR-B1 nuclear receptor as well as SREBP transcription factors responses 341	
associated with cholesterol uptake are been proposed in the MTC-1 cells with PFOA 342	
exposure. In order to further investigate the effects of PFOA on the cholesterol biosynthesis 343	
pathway in MLTC-1 cells, the expression of a series of important genes in this pathway 344	
were determined by quantitative real-time RT PCR. The general down-regulation gene 345	
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expression profiles are in agreement with the cells’ cholesterol metabolism content. 346	
Specifically, HMGCR is an enzyme involved in mevalonate synthesis and is a rate limiting 347	
enzyme in cholesterol synthesis pathway. It was down-regulated by PFOA in rat liver with 348	
resulting decreased cholesterol content, while up-regulated in human liver cells resulting in 349	
increased cholesterol content [31, 32]. These inconsistent effects may result from different 350	
species and experimental models, which have unique metabolic mechanisms. Meanwhile, 351	
acyl-CoA is an important raw material for cholesterol biosynthesis, which is altered via fatty 352	
acids transport [32]. This study is consistent with previous MLTC-1 cells results showing 353	
that PFOA can inhibit cholesterol biosynthesis in vitro [9]. Herein, PFOA may disrupt 354	
cholesterol by both exogenous cholesterol uptake and endogenous cholesterol biosynthesis. 355	
Regarding male reproductive function, the level of testosterone in MLTC-1 cells is 356	
significantly stimulated to 1.84-fold of the control at lower PFOA concentrations (100 µM) 357	
and inhibited to 0.50-fold of the control at higher treatment concentrations (200 µM). We 358	
observed significant decreases in mRNA levels of three genes (StAR, 3β-HSD, CYP17α) that 359	
play pivotal roles in testosterone production in MLTC-1 cells exposed by PFOA. StAR is 360	
responsible for carrying cholesterol into the inner mitochondrial membrane from the outer 361	
mitochondrial membrane, which subsequently converts into pregnenolone by P450SCC in the 362	
inner mitochondrial membrane and finally into progesterone via 3β-HSD catalysis (Fig. 5B). 363	
Previous studies have shown that PFCs inhibit the expression of several key enzymes, 364	
including StAR, 3β-HSD and CYP17α [9, 37, 38]. However, in the present study, low 365	
exposure concentrations of PFOA stimulated testosterone production and high concentrations 366	
of PFOA inhibited testosterone production, though the process occurred without any 367	
	 18	
alteration of MLTC-1 cell viability. This can be explained by the fact that many 368	
environmental endocrine disruptor chemicals are reported to exhibit the ability to induce U 369	
and/or invert U dose-response trends, which results into low-dose stimulation responses [39]. 370	
Similar studies have shown that exposures to low or high levels of phthalates or prolactin 371	
have biphasic effects on testosterone production in MLTC-1 cells [40-42]. Alteration of 372	
cholesterol transport and steroidogenic enzymes in MLTC-1 cells may be involved in the 373	
biphasic effects of PFOA on androgen production. Our findings agree with the hypothesis 374	
that low-dose stimulation corresponds to a negative feedback compensation mechanism that 375	
counterbalances the endocrine disrupting chemicals-induced inhibition of gene expression of 376	
the steroidogenic enzymes [43-44]. In conclusion, our results suggest that PFOA disrupts 377	
cholesterol precursor fatty acid transport into mitochondria and then alters cholesterol 378	
synthesis. Meanwhile, PFOA-regulated nuclear (membrane) receptor response and 379	
steroidogenesis result in disruption of sex hormones secretion. In particular, PFOA has a 380	
biphasic effect on testosterone and progesterone production. 381	
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Figure Legends 531	
 532	
Figure 1. The viability of MLTC-1 cells exposed to various concentrations of PFOA (0-300 533	
µM) for 48 h. The values are expressed as the means (±SEM) of survival (% of control cells). 534	
Data were analysed by one-way ANOVA with Tukey’s multiple comparisons test. Asterisks 535	
above columns indicate a significant difference in comparison to the control, * p ≤0.05, ** p 536	
≤0.01. 537	
 538	
Figure 2. Effects of PFOA on the mRNA expression of receptor genes. MLTC-1 cells were 539	
exposed to different doses of PFOA (0, 50, 100 or 200 µM) for 48 h. The relative mRNA 540	
expression of PPARα, AR, PXR, LHR and SR-B1 gene were measured by quantitative 541	
real-time RT PCR. The experiments were repeated four times in duplicate. Data were 542	
analysed by one-way ANOVA with Tukey’s multiple comparisons test. Asterisks above 543	
columns indicate a significant difference in comparison to the control, * p ≤0.05, ** p ≤0.01. 544	
 545	
Figure 3. Effects of PFOA on the subcellular accumulation (A), fatty acids mitochondria 546	
transport genes expression (B) in MLTC-1 cells and schematic diagram of fatty acids 547	
mitochondrial transport (C).  548	
Mean ± SEM is derived from four independent experiments. Fraction isolated: cytoplasm and 549	
mitochondria. 550	
 551	
 552	
	 25	
Figure 4. PFOA affect cholesterol biosynthetic pathways gene expression and content in 553	
MLTC-1 cells. Heat map displays fold-changes of PFOA exposure on cholesterol 554	
biosynthetic pathways gene expression profiles (A), effects of PFOA on the cholesterol 555	
biosynthesis pathway gene expression in MLTC-1 cells in 200 µM treatment (B), and effects 556	
of PFOA exposure on cholesterol level in MLTC-1 cells (C).  557	
Colour scales range from bright red to bright green corresponding to up- or down-regulation 558	
of gene expression, respectively. The experiments were repeated four times in duplicate. Data 559	
were analysed by one-way ANOVA with Tukey’s multiple comparisons test. Asterisks above 560	
columns indicate a significant difference in comparison to the control, * p ≤0.05, ** p ≤0.01. 561	
 562	
Figure 5. PFOA affect steroid hormone biosynthetic pathways in MLTC-1 cells, 563	
steroidogenesis gene expression (A), steroidogenesis gene pathway (B), 17-OH progesterone 564	
secretion (C), and testosterone secretion (D). 565	
The experiments were repeated four times in duplicate. Data were analysed by one-way 566	
ANOVA with Tukey’s multiple comparisons test. Asterisks above columns indicate a 567	
significant difference in comparison to the control, * p ≤0.05, ** p ≤0.01. 568	
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Table 1. Sequence of primers used for quantitative real-time PCR. 570	
Gene Accession number Primer sequence (5‘-3’) Product size (bp) 
GAPDH NM_001289746.1 
F：GTATTGGGCGCCTGGTCACC  
R：CGCTCCTGGAAGATGGTGATGG 
    202 
CPTii XM_006531658.3 
F: AACAACCGTAGGCTCCACCGT 
R: ATTCAAAAGACTTCGGGGGAC 
99 
CACT NM_020520.4 
F: CAGATTCAGGCTTCTTCAGGG 
R: ACTGGCAGGAACATCTCGCAT 
135 
CPTii NM_009949.2 
F: TGGCTTTCCTGCGACAGTATG  
R: GGCGAATAGTCTCTGTGCGGC 
93 
CAT XM_006497646.3 
F: AAGTCAAAGAGACCACCCACG 
R: GGAGGTTAGGATGCCAACAGG 
177 
PPARα XM_006520624.3 
F: GGAGAACAAGAGACGAGGGTG 
R: CAGGGACTGAGGAAAAGGGAC 
157 
AR NM_013476.4 
F: CTTTCAAGGGAGGTTACGCCA 
R: ACAGAGACAGAGAGGACGGGA 
111 
PXR XM_006521848.3 
F: TGAAAGACAGGGTTCCAATGA 
R: GTGTGGCAGAAGAGGGATGAT 
119 
LHR XM_006523723.2 
F：GAGAAGCGAATAACGAGACG 
R：AGCCAAATCAACACCCTAAG 
178 
SR-B1 XM_017320764.1 
F：TTGTTCTACCTCCTCTCTCGC 
R：CTGACCCCCCACCTCTACCTT 
179 
StAR NM_011485.5 
F：TGGAAAAGACACGGTCATCA 
R：CTCCGGCATCTCCCCAAAAT 
154 
P450SCC NM_001346787.1 
F：CGTGACCAGAAAAGACAACA 
R：AGGATGAAGGAGAGGAGAGC 
152 
3β-HSD NM_001304800.1 
F：AGTGATGGAAAAAGGGCAGGT 
R：GCAAGTTTGTGAGTGGGTTAG 
167 
CYP17α NM_007809.3 
F：TGGGCACTGCATCACGATAA 
R：GCTCCGAAGGGCAAATAACT 
122 
17β-HSD NM_008291.3 F：AACGCAACATCAGCAACAGA 
R：CAGCCCCACCTCACCCTACC 
88 
HMGCS1 NM_001291439.1 
F：GCTGTCATCAGTAACGGGGAG 
R：CCAAGACATCCATTCCTCCAA 
99 
HMGCR XM_006517531.1 
F：ACCAAACCCCGTAACCCAAAG 
R：GCCAAAAGGAAGGCTAAACTC 
255 
MVK XM_006530185.3 F：GAGCAATGGGAAAGTGAGCGT 
R：GGAGGTCCCCCATCTTCTTTA 
161 
PMVK NM_026784.3 F：AGGCTCTTTCCCTTCCAGTTT 
R：GTCCTTCCCGGATTTTCTCTT 
255 
MVD NM_138656.2 
F：ACAAGAAGCAGACGGGCAGTA 
R：AGGTAGGAGATCGGTGGGAAG 
217 
IDI1 XM_006498513.3 
F：ATCCACCTTCCTCTGACTCCC 
R：AGCCCTACTCCTTCCCACTTC 
161 
FDPS NM_001253751.1 F：ACAGTGGGCTGGTGTGTAGAA 
R：CAGAAGCAGAGCGTCGTTGAT 
147 
FDFT1 XM_006518547.3 F：GAACTCATAACCAACACCCTA 
R：CCTTCCGAATCTTCACTACTC 
175 
SQLE NM_009270.3 
F：ACAGCCACATTCGCACCCCTC 
R：CATTTAAAGCCTGCCTACCCC 
107 
	 27	
LSS XM_006513284.3 
F：CTCCAGAATGAGTTGGGTCGG 
R：GCTGTTTGCGCTTTTGGTAAG 
143 
CYP51A1 NM_020010.2 
F：TTTCCGAGAAGCGGTGTGCGA 
R：ACGGCGAGACGGAACAGGTAG 
207 
SC4MOL NM_025436.2 F：TTTGGCAAGGTGTTTGGGCTG 
R：CAAGGGATGTGCGTATTCTGC 
157 
NSDHL NM_010941.3 F：CTGAAGACCTCCCTTACGCCA 
R：TTCTTAGGGTCGTTGGCATCC 
97 
SC5DL XM_006510253.2 
F：GCTTTTCACCCTGTGGACGGC 
R：CTGGGGAACCCGAAAATCACC 
153 
DHCR7 XM_006508479.3 
F：TTGAAGAAGGGAGGCTTTTTT 
R：AGGTGGATGAGCTGCTAGGTG 
191 
 571	
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Table 2 Effect of PFOA on mRNA expression of cholesterol biosynthetic pathways genes in 573	
MLTC-1 cells 574	
 575	
 DMSO 50 µM PFOA  100 µM PFOA 200 µM PFOA 
HMGCS  1.00 ± 0.02 0.92 ± 0.04 0.82 ± 0.05** 0.49 ± 0.07** 
HMGCR 1.00 ± 0.05 0.85 ± 0.11* 0.82 ± 0.05** 0.36 ± 0.05** 
MVK  1.00 ± 0.04 1.52 ± 0.14** 1.27 ± 0.12* 0.87 ± 0.07 
PMVK 1.00 ± 0.03 1.52 ± 0.15** 1.26 ± 0.09* 0.73 ± 0.03* 
MVD 1.00 ± 0.08 1.23 ± 0.14* 1.17 ± 0.11 0.58 ± 0.07** 
IDI1 1.00 ± 0.08 0.90 ± 0.08 0.75 ± 0.04** 0.37 ± 0.05** 
FDPS 1.00 ± 0.10 1.35 ± 0.09** 1.09 ± 0.05 0.43 ± 0.08** 
FDFT1 1.00 ± 0.06 0.89 ± 0.04* 0.84 ± 0.03** 0.58 ± 0.03** 
SQLE 1.00 ± 0.04 0.87 ± 0.07* 0.80 ± 0.05** 0.36 ± 0.04** 
LSS 1.00 ± 0.05 1.13 ± 0.08 1.22 ± 0.11 0.43 ± 0.08** 
CYP5 1.00 ± 0.06 1.74 ± 0.08** 1.35 ± 0.17* 0.29 ± 0.04** 
SC4MOL 1.00 ± 0.03 1.07 ± 0.07 0.98 ± 0.06 0.44 ± 0.08** 
NSDHLC 1.00 ± 0.09 0.97 ± 0.02 1.09 ± 0.09 0.53 ± 0.05** 
SC5DL 1.00 ± 0.07 0.92 ± 0.08 0.87 ± 0.02* 0.48 ± 0.07** 
DHCR7 1.00 ± 0.08 1.05 ± 0.02 1.01 ± 0.06 1.10 ± 0.02 
	576	
Data are represented as mean ± SEM of four independent experiments that were performed in 577	
duplicate. The one-way analysis of variance (ANOVA) with Tukey’s multiple comparisons 578	
test was applied to estimate for statistical significance between controls versus treatment 579	
groups. Asterisks indicate a significant difference relative to control, * p ≤0.05, ** p ≤0.01 580	
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Figure 1 582	
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Figure 5 598	
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